Metraipolis › archive › dc_23759596be8f

Protective effects of Shenkang injection against diabetic kidney disease via p38 MAPK/NFκB/MCP-1/CCR2 pathway inhibition — Europe PMC PMID:40995594

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40995594
DOI
10.3389/fendo.2025.1596000
License (as archived)
solo-consultazione
Archived
2026-11-10T01:19:10.367Z
SHA-256 of the archived text
1269bc4f7e2b5864ae0cdddf4e388ff1db675c9b54049d0b612830976f09d4ec
Stable URL of this page
https://metraipolis.com/documento/dc_23759596be8f

How to cite

Protective effects of Shenkang injection against diabetic kidney disease via p38 MAPK/NFκB/MCP-1/CCR2 pathway inhibition — Europe PMC PMID:40995594 — Europe PMC (en), https://europepmc.org/article/MED/40995594 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_23759596be8f (Metraipolis archive dc_23759596be8f, sha256 1269bc4f7e2b5864ae0cdddf4e388ff1db675c9b54049d0b612830976f09d4ec)
BibTeX
@misc{dc23759596be8f,
  title = {Protective effects of Shenkang injection against diabetic kidney disease via p38 MAPK/NFκB/MCP-1/CCR2 pathway inhibition — Europe PMC PMID:40995594},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40995594},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_23759596be8f; sha256 1269bc4f7e2b5864ae0cdddf4e388ff1db675c9b54049d0b612830976f09d4ec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40995594. Agents can read the archived copy with the MCP tool read_document.